ARCHIVES

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

This article is from The Cancer Letter archive.

Vol. 07 No. 04 | January 23, 1981

Download PDF Visit The Full Archive

Related Articles

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

Funding opportunities listed.

September 24, 2004

ACCC Members To Lobby, Hear Discussion on Oncology Unit

January 6, 1978

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics

September 28, 1979

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005